StockData
Pulsenmore Ltd. logo

Pulsenmore Ltd. (PLSM) company profile

PLSMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 30, 2026Score 3/30
$1.35−0.06 (-4.26%)

Close on Nov 17, 2026Market cap $8.78MP/E 1.8Yield –

About Pulsenmore

Surgical & Medical Instruments & Apparatus, SIC 3841

Pulsenmore Ltd. is a medical device company that develops, manufactures, and markets portable, non-invasive ultrasound solutions designed for home use. The company offers two main products, the Pulsenmore ES and Pulsenmore FC, while also developing the Pulsenmore MC and an assisted service for conducting biophysical profile tests in high-risk pregnancies. Its technology enables home-based ultrasound scans across obstetrics and gynecology, with applications extending to pulmonary medicine, cardiology, and urology. Pulsenmore provides its solutions primarily to healthcare organizations and patient end-users, including an ongoing commercial relationship with Clalit Health Services.

The company maintains its principal executive offices and operational headquarters in Omer, Israel. Pulsenmore focuses on commercializing its ultrasound devices across domestic and global markets, with business operations and revenue activities spanning Israel, the United States, Europe, and South Korea. Manufacturing and final device assembly are supported through third-party subcontractors.

Summary of the business section of Pulsenmore's latest annual report, written by StockData.

Company profile

Company

Legal name
Pulsenmore Ltd.
Founded
2014
Headquarters
Israel, Israel
Address
Omarim 8, Omer 8496500
Phone
972 52 606 2075
Employees
63, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
L3
Fiscal year ends
December 31
Auditor
Kesselman & Kesselman, Tel-Aviv, Israel

Stock & identifiers

Ticker
PLSM
Exchange
Nasdaq
IPO date
Jan 21, 2026
Shares outstanding
7M, Mar 15, 2026
Filer category
Non-accelerated filer<br>Emerging growth company
SEC CIK
2064764
CUSIP
M8S7C5117
FIGI
BBG0183CJX53
Share class FIGI
BBG010YGFQF5
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Elazar SonnenscheinChief Executive Officer, Director1,881,351
David WoodsChief Commercial Officer–
Minelu SonnenscheinVP R&D–
Michael HamelsdorfGC & Corporate Secretary–
Meir ShmouelyVP Software Development13,812
Eran HirshChief Financial Officer–
Racheli Guz-LaviDirector46,874
Hagai ItkinDirector–
Linda MessalemDirector–
Anat LoewensteinDirector–
Jonathan AderethDirector129,062

See a number that looks wrong?